Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
April 13, 2026 — Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
March 23, 2026 — Dr. Hawkins will contribute to the development of automated reaction sampling technology and Self-Driving Labs.
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
March 16, 2026 — The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs
Telescope Strengthens Investor Communications Strategy
March 12, 2026 — Telescoped has rescoped previously announced digital marketing agreements
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
February 23, 2026 — Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL market
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
January 30, 2026 — The Company generated revenues of $2.7 million during this period.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
January 27, 2026 — The Company is pleased to provide an update on the progress of its lithium processing portfolio.
Telescope Innovations Plans Expansion of DirectInject-LC™ Technology Ecosystem to Fuel the Physical AI Revolution
January 20, 2026 — Telescope is currently developing two new advanced analytical versions: DirectInject-IC™, and DirectInject-ICP™.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
January 5, 2026 — Telescope provides a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI.
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
December 23, 2025 — The Company generated revenues of $5.8 million during FY25, with an Adjusted EBITDA loss of $402K
